Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.240
-0.290-3.04%
Volume:136.48M
Turnover:1.25B
Market Cap:106.46B
PE:23.31
High:9.440
Open:9.435
Low:9.080
Close:9.530
52wk High:11.203
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.04
T/O Rate:1.18%
Dividend:0.34
Dividend Rate:3.64%
EPS(LYR):0.396
ROE:20.90%
ROA:10.70%
PB:2.43
PE(LYR):23.31
PS:2.91

Loading ...

CSPC Says NMPA Accepts NDA for Anbenitamab, Albumin-Bound Docetaxel Neoadjuvant Breast Cancer Combo Under Priority Review

Reuters
·
Aug 04

Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)

Reuters
·
Aug 04

CSPC Pharma Begins Phase Ib/II Trial of Colorectal Cancer Drug Candidate

MT Newswires Live
·
Aug 03

CSPC Pharmaceutical - Initiates Phase Ib/Ii Trial of Sys 6090 Injection for Colorectal Cancer in China

THOMSON REUTERS
·
Aug 03

CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong

Dow Jones
·
Aug 03

Movement Alert|CSPC PHARMA Falls 3.03% in Regular Trading, Trading at HK$8.31

Market Focus
·
Aug 03

CSPC Pharma Wins China Trial Approval for RSV Vaccine

MT Newswires Live
·
Aug 03

CSPC Pharmaceutical Group's SYS6041 Combination Therapy Phase II Trial for Recurrent Ovarian Cancer Has Officially Launched at the First Center in China

Stock News
·
Jul 31

CSPC Pharma Secures NMPA Clearance to Begin Clinical Trials for Second Recombinant RSV Vaccine

Bulletin Express
·
Jul 31

CSPC Pharma Says China Clears Clinical Trial for RSV Vaccine Candidate SYS 6057

Reuters
·
Jul 31

CSPC Pharmaceutical - Pharma's Recombinant Rsv Vaccine (Sys6057) Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Jul 31

CSPC Pharma Ramps up Usd/rmb Hedging with FX Swap, Forwards Totaling USD 344 Million

Reuters
·
Jul 30

CSPC Pharmaceutical - Unit Enters FX Swap and FX Forward Contracts with Icbc Since June 16, 2026

THOMSON REUTERS
·
Jul 30

CSPC Pharmaceutical - Zhongqi to Place USD 3.19 Mln Security Deposit for FX Swap Contract

THOMSON REUTERS
·
Jul 30

CSPC Pharmaceutical Starts Phase 2 Trial of Hypertension Drug

MT Newswires Live
·
Jul 30

Movement Alert|CSPC PHARMA Falls 3.2% in Regular Trading, Trading at 8.47 HKD

Market Focus
·
Jul 30

CSPC Pharma Initiates First Chinese Site for Phase II Trial of siRNA Hypertension Therapy SYH2062

Bulletin Express
·
Jul 29

CSPC PHARMA: FDA Clears Registrational Trial of Nectin-4 ADC CRB-701 for Second-Line Oropharyngeal Cancer

Bulletin Express
·
Jul 29

CSPC Pharma's CRB-701 (SYS 6002) Gets FDA Nod for Phase 2 Trial in Oropharyngeal Cancer

Stock News
·
Jul 29

CSPC Says FDA Clears Crb-701 Pivotal Trial in Second-line Oropharyngeal Cancer

Reuters
·
Jul 29